Korea Arlico Pharm Co., Ltd.

Korea Arlico Pharm Co., Ltd. is a leading supplier in the pharmaceutical industry, specialising in the Contract Development and Manufacturing (CDMO) of generic pharmaceuticals. Established in a PIC/S GMP facility, the company has navigated numerous challenges over its impressive 30-year journey, culminating in its recognition as one of the top 50 pharmaceutical companies in Korea. In 2018, Korea Arlico Pharm was successfully listed on KOSDAQ, showcasing its growth and stability. The company has maintained a remarkable average annual sales growth rate of 23% from 2015 to 2022, bolstered by its extensive nationwide sales networks and capabilities.

Services include:
- Contract Development and Manufacturing (CDMO)
- Production of generic pharmaceuticals

As a forward-thinking organisation, Korea Arlico Pharm Co., Ltd. continues to enhance its offerings and maintain its position in the competitive pharmaceutical landscape. For more information, please visit arlico.co.kr.